Comparative proteomic analysis of ductal breast carcinoma demonstrates an altered expression of chaperonins and cytoskeletal proteins

Molecular Medicine Reports

Volumn 7, Issue 5, 2013, Pages 1700-1704

  Carcoforo, Paolo ^a   Ura, Blendi ^d   Mischiati, Carlo ^a   Squerzanti, Monica ^a   Lanzara, Vincenzo ^a   Cervellati, Carlo ^a   Calza, Roberta ^a   De Laureto, Patrizia Polverino ^b   Frare, Erica ^b   Portinari, Mattia ^a   Feriotto, Giordana ^a   Lanzara, Serena ^a   Agostinelli, Enzo ^c   Bergamini, Carlo M ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Breast cancer; Cancer biomarkers; Proteomics

Indexed keywords

CHAPERONIN; CYTOKERATIN; CYTOSKELETON PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; PHENOTYPE; PROTEIN ANALYSIS; PROTEOMICS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHAPERONINS; CYTOSKELETAL PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; NEOPLASM PROTEINS; PROTEOMICS;

EID: 84875995957     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1375     Document Type: Article

References (26)

1. Pisani P, Bray F and Parkin DM: Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97: 72-81, 2002.
2. Sørlie T, Perou CM, Tibshirani R, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869-10874, 2001.
3. Gast MC, Schellens JH and Beijnen JH: Clinical proteomics in breast cancer: a review. Breast Cancer Res Treat 116: 17-29, 2009.
4. Bozzo C, Spolaore B, Toniolo L, et al: Nerve influence on myosin light chain phosphorylation in slow and fast skeletal muscles. FEBS J 272: 5771-5785, 2005.
5. Shevchenko A, Tomas H, Havlis J, Olsen JV and Mann M: In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1: 2856-2860, 2006.
6. Galvão ER, Martins LM, Ibiapina JO, Andrade HM and Monte SJ: Breast cancer proteomics: a review for clinicians. J Cancer Res Clin Oncol 137: 915-925, 2011.
7. Acunzo J, Katsogiannou M and Rocchi P: Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death. Int J Biochem Cell Biol 44: 1622-1631, 2012.
8. Keeling J and McKee GT: Heat shock protein (HSP)27: a further refinement in the diagnosis of suspicious fine needle aspirates of breast. Cytopathology 10: 40-49, 1999.
9. Yang Y and Li Z: Roles of heat shock protein gp96 in the ER quality control: redundant or unique function? Mol Cells 20: 173-182, 2005.
10. Randazzo M, Terness P, Opelz G and Kleist C: Active-specific immunotherapy of human cancers with the heat shock protein Gp96-revisited. Int J Cancer 130: 2219-2231, 2012.
11. Brackley KI and Grantham J: Activities of the chaperonin containing TCP-1 (CCT): implications for cell cycle progression and cytoskeletal organisation. Cell Stress Chaperones 14: 23-31, 2009.
12. Ambrosino C, Tarallo R, Bamundo A, et al: Identification of a hormone-regulated dynamic nuclear actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. Mol Cell Proteomics 9: 1352-1367, 2010.
13. Vainberg IE, Lewis SA, Rommelaere H, et al: Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell 93: 863-873, 1998.
14. Razandi M, Pedram A and Levin ER: Heat shock protein 27 is required for sex steroid receptor trafficking to and functioning at the plasma membrane. Mol Cell Biol 30: 3249-3261, 2010.
15. Jiang P, Enomoto A and Takahashi M: Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett 284: 122-130, 2009.
16. Le Naour F, Misek DE, Krause MC, Deneux L, Giordano TJ, Scholl S and Hanash SM: Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res 7: 3328-3335, 2001.
17. Tamesa MS, Kuramitsu Y, Fujimoto M, et al: Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. Electrophoresis 30: 2168-2181, 2009.
18. Shukla S, Pranay A, D'Cruz AK, Chaturvedi P, Kane SV and Zingde SM: Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response. Cancer Biomark 5: 127-135, 2009.
19. Zhang XZ, Xiao ZF, Li C, et al: Triosephosphate isomerase and peroxiredoxin 6, two novel serum markers for human lung squamous cell carcinoma. Cancer Sci 100: 2396-2401, 2009.
20. Fu XM, Wang P and Zhu BT: Characterization of the estradiol-binding site structure of human protein disulfide isomerase (PDI). PLoS One 6: e27185, 2011.
21. Hashida T, Kotake Y and Ohta S: Protein disulfide isomerase knockdown-induced cell death is cell-line-dependent and involves apoptosis in MCF7 cells. J Toxicol Sci 1: 1-7, 2011.
22. Boiteux G, Lascombe I, Roche E, Plissonnier ML, Clairotte A, Bittard H and Fauconnet S: A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells. Int J Cancer 124: 1820-1828, 2009.
23. Schachtrup C, Emmler T, Bleck B, Sandqvist A and Spener F: Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins. Biochem J 382: 239-245, 2004.
24. Hancke K, Grubeck D, Hauser N, Kreienberg R and Weiss JM: Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res Treat 119: 367-377, 2010.
25. Li H, Lu Q, Dong LH, Xue H, Zhou HY and Yang HJ: Expression of fatty acid binding protein in human breast cancer tissues. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23: 312-316, 2007.
26. Elston CW and Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991.